Found 140 hits Enz. Inhib. hit(s) with all data for entry = 50012085 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Coagulation factor X
(Homo sapiens (Human)) | BDBM12751
(1-(3-carbamimidoylphenyl)-3-methyl-N-[4-(2-sulfamo...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cccc(c1)C(N)=N Show InChI InChI=1S/C24H22N6O3S/c1-15-13-21(30(29-15)19-6-4-5-17(14-19)23(25)26)24(31)28-18-11-9-16(10-12-18)20-7-2-3-8-22(20)34(27,32)33/h2-14H,1H3,(H3,25,26)(H,28,31)(H2,27,32,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| 0.0130 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Tested for binding affinity against human Coagulation factor Xa (trypsin-like serine protease) |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114434
(2-(3-Fluoro-naphthalen-2-yl)-5-methyl-2H-pyrazole-...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1F Show InChI InChI=1S/C27H21FN4O3S/c1-17-14-25(32(31-17)24-16-20-7-3-2-6-19(20)15-23(24)28)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-26(22)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| 5.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Tested for inhibitory activity against Coagulation factor Xa (trypsin-like serine protease) of the compound |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Serine protease 1
(Homo sapiens (Human)) | BDBM12751
(1-(3-carbamimidoylphenyl)-3-methyl-N-[4-(2-sulfamo...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cccc(c1)C(N)=N Show InChI InChI=1S/C24H22N6O3S/c1-15-13-21(30(29-15)19-6-4-5-17(14-19)23(25)26)24(31)28-18-11-9-16(10-12-18)20-7-2-3-8-22(20)34(27,32)33/h2-14H,1H3,(H3,25,26)(H,28,31)(H2,27,32,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| 16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Tested for the binding affinity against trypsin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM12751
(1-(3-carbamimidoylphenyl)-3-methyl-N-[4-(2-sulfamo...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cccc(c1)C(N)=N Show InChI InChI=1S/C24H22N6O3S/c1-15-13-21(30(29-15)19-6-4-5-17(14-19)23(25)26)24(31)28-18-11-9-16(10-12-18)20-7-2-3-8-22(20)34(27,32)33/h2-14H,1H3,(H3,25,26)(H,28,31)(H2,27,32,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Tested for the binding affinity against thrombin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114453
(2-(6-Chloro-naphthalen-2-yl)-5-trifluoromethyl-2H-...)Show SMILES NS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(nn2-c2ccc3cc(Cl)ccc3c2)C(F)(F)F)cc1 Show InChI InChI=1S/C27H18ClF3N4O3S/c28-19-9-5-18-14-21(12-8-17(18)13-19)35-23(15-25(34-35)27(29,30)31)26(36)33-20-10-6-16(7-11-20)22-3-1-2-4-24(22)39(32,37)38/h1-15H,(H,33,36)(H2,32,37,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114435
(2-(3-Cyano-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C#N Show InChI InChI=1S/C28H21N5O3S/c1-18-14-26(33(32-18)25-16-21-7-3-2-6-20(21)15-22(25)17-29)28(34)31-23-12-10-19(11-13-23)24-8-4-5-9-27(24)37(30,35)36/h2-16H,1H3,(H,31,34)(H2,30,35,36) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114434
(2-(3-Fluoro-naphthalen-2-yl)-5-methyl-2H-pyrazole-...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1F Show InChI InChI=1S/C27H21FN4O3S/c1-17-14-25(32(31-17)24-16-20-7-3-2-6-19(20)15-23(24)28)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-26(22)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114436
(2-(6-Chloro-naphthalen-2-yl)-5-methyl-2H-pyrazole-...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2cc(Cl)ccc2c1 Show InChI InChI=1S/C27H21ClN4O3S/c1-17-14-25(32(31-17)23-13-9-19-15-21(28)10-6-20(19)16-23)27(33)30-22-11-7-18(8-12-22)24-4-2-3-5-26(24)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114439
(2-(6-Bromo-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2cc(Br)ccc2c1 Show InChI InChI=1S/C27H21BrN4O3S/c1-17-14-25(32(31-17)23-13-9-19-15-21(28)10-6-20(19)16-23)27(33)30-22-11-7-18(8-12-22)24-4-2-3-5-26(24)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114450
(2-(3-Carbamimidoyl-naphthalen-2-yl)-5-methyl-2H-py...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C(N)=N Show InChI InChI=1S/C28H24N6O3S/c1-17-14-25(34(33-17)24-16-20-7-3-2-6-19(20)15-23(24)27(29)30)28(35)32-21-12-10-18(11-13-21)22-8-4-5-9-26(22)38(31,36)37/h2-16H,1H3,(H3,29,30)(H,32,35)(H2,31,36,37) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114443
(5-Methyl-2-(3-sulfamoyl-naphthalen-2-yl)-2H-pyrazo...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1S(N)(=O)=O Show InChI InChI=1S/C27H23N5O5S2/c1-17-14-24(32(31-17)23-15-19-6-2-3-7-20(19)16-26(23)39(29,36)37)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-25(22)38(28,34)35/h2-16H,1H3,(H,30,33)(H2,28,34,35)(H2,29,36,37) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114437
(2-(3-Carbamoyl-naphthalen-2-yl)-5-methyl-2H-pyrazo...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C(N)=O Show InChI InChI=1S/C28H23N5O4S/c1-17-14-25(33(32-17)24-16-20-7-3-2-6-19(20)15-23(24)27(29)34)28(35)31-21-12-10-18(11-13-21)22-8-4-5-9-26(22)38(30,36)37/h2-16H,1H3,(H2,29,34)(H,31,35)(H2,30,36,37) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114451
(2-(3-Fluoro-naphthalen-2-yl)-5-trifluoromethyl-2H-...)Show SMILES NS(=O)(=O)c1ccccc1-c1ccc(NC(=O)c2cc(nn2-c2cc3ccccc3cc2F)C(F)(F)F)cc1 Show InChI InChI=1S/C27H18F4N4O3S/c28-21-13-17-5-1-2-6-18(17)14-22(21)35-23(15-25(34-35)27(29,30)31)26(36)33-19-11-9-16(10-12-19)20-7-3-4-8-24(20)39(32,37)38/h1-15H,(H,33,36)(H2,32,37,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114444
(2-(3-Aminomethyl-naphthalen-2-yl)-5-methyl-2H-pyra...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1CN Show InChI InChI=1S/C28H25N5O3S/c1-18-14-26(33(32-18)25-16-21-7-3-2-6-20(21)15-22(25)17-29)28(34)31-23-12-10-19(11-13-23)24-8-4-5-9-27(24)37(30,35)36/h2-16H,17,29H2,1H3,(H,31,34)(H2,30,35,36) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114433
(2-(3-Methanesulfonyl-naphthalen-2-yl)-5-methyl-2H-...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1S(C)(=O)=O Show InChI InChI=1S/C28H24N4O5S2/c1-18-15-25(32(31-18)24-16-20-7-3-4-8-21(20)17-27(24)38(2,34)35)28(33)30-22-13-11-19(12-14-22)23-9-5-6-10-26(23)39(29,36)37/h3-17H,1-2H3,(H,30,33)(H2,29,36,37) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114446
(5-Methyl-2-naphthalen-2-yl-2H-pyrazole-3-carboxyli...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2ccccc2c1 Show InChI InChI=1S/C27H22N4O3S/c1-18-16-25(31(30-18)23-15-12-19-6-2-3-7-21(19)17-23)27(32)29-22-13-10-20(11-14-22)24-8-4-5-9-26(24)35(28,33)34/h2-17H,1H3,(H,29,32)(H2,28,33,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 104 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114438
(2-(3-Bromo-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1Br Show InChI InChI=1S/C27H21BrN4O3S/c1-17-14-25(32(31-17)24-16-20-7-3-2-6-19(20)15-23(24)28)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-26(22)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 143 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114447
(3-[3-Methyl-5-(2'-sulfamoyl-biphenyl-4-ylcarbamoyl...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C(O)=O Show InChI InChI=1S/C28H22N4O5S/c1-17-14-25(32(31-17)24-16-20-7-3-2-6-19(20)15-23(24)28(34)35)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-26(22)38(29,36)37/h2-16H,1H3,(H,30,33)(H,34,35)(H2,29,36,37) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 376 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114432
(2-(3-Hydroxymethyl-naphthalen-2-yl)-5-methyl-2H-py...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1CO Show InChI InChI=1S/C28H24N4O4S/c1-18-14-26(32(31-18)25-16-21-7-3-2-6-20(21)15-22(25)17-33)28(34)30-23-12-10-19(11-13-23)24-8-4-5-9-27(24)37(29,35)36/h2-16,33H,17H2,1H3,(H,30,34)(H2,29,35,36) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 483 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114449
(3-[3-Methyl-5-(2'-sulfamoyl-biphenyl-4-ylcarbamoyl...)Show SMILES COC(=O)c1cc2ccccc2cc1-n1nc(C)cc1C(=O)Nc1ccc(cc1)-c1ccccc1S(N)(=O)=O Show InChI InChI=1S/C29H24N4O5S/c1-18-15-26(33(32-18)25-17-21-8-4-3-7-20(21)16-24(25)29(35)38-2)28(34)31-22-13-11-19(12-14-22)23-9-5-6-10-27(23)39(30,36)37/h3-17H,1-2H3,(H,31,34)(H2,30,36,37) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 545 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114452
(2-[3-(N,N-Dimethyl-carbamimidoyl)-naphthalen-2-yl]...)Show SMILES CN(C)C(=N)c1cc2ccccc2cc1-n1nc(C)cc1C(=O)Nc1ccc(cc1)-c1ccccc1S(N)(=O)=O Show InChI InChI=1S/C30H28N6O3S/c1-19-16-27(36(34-19)26-18-22-9-5-4-8-21(22)17-25(26)29(31)35(2)3)30(37)33-23-14-12-20(13-15-23)24-10-6-7-11-28(24)40(32,38)39/h4-18,31H,1-3H3,(H,33,37)(H2,32,38,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114441
(2-(6-Methoxy-naphthalen-2-yl)-5-methyl-2H-pyrazole...)Show SMILES COc1ccc2cc(ccc2c1)-n1nc(C)cc1C(=O)Nc1ccc(cc1)-c1ccccc1S(N)(=O)=O Show InChI InChI=1S/C28H24N4O4S/c1-18-15-26(32(31-18)23-13-9-21-17-24(36-2)14-10-20(21)16-23)28(33)30-22-11-7-19(8-12-22)25-5-3-4-6-27(25)37(29,34)35/h3-17H,1-2H3,(H,30,33)(H2,29,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 3.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114445
(2-(6-Hydroxy-naphthalen-2-yl)-5-methyl-2H-pyrazole...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2cc(O)ccc2c1 Show InChI InChI=1S/C27H22N4O4S/c1-17-14-25(31(30-17)22-12-8-20-16-23(32)13-9-19(20)15-22)27(33)29-21-10-6-18(7-11-21)24-4-2-3-5-26(24)36(28,34)35/h2-16,32H,1H3,(H,29,33)(H2,28,34,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 3.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50114448
(2-[3-(4,5-Dihydro-1H-imidazol-2-yl)-naphthalen-2-y...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C1=NCCN1 |t:40| Show InChI InChI=1S/C30H26N6O3S/c1-19-16-27(30(37)34-23-12-10-20(11-13-23)24-8-4-5-9-28(24)40(31,38)39)36(35-19)26-18-22-7-3-2-6-21(22)17-25(26)29-32-14-15-33-29/h2-13,16-18H,14-15H2,1H3,(H,32,33)(H,34,37)(H2,31,38,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 7.82E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114452
(2-[3-(N,N-Dimethyl-carbamimidoyl)-naphthalen-2-yl]...)Show SMILES CN(C)C(=N)c1cc2ccccc2cc1-n1nc(C)cc1C(=O)Nc1ccc(cc1)-c1ccccc1S(N)(=O)=O Show InChI InChI=1S/C30H28N6O3S/c1-19-16-27(36(34-19)26-18-22-9-5-4-8-21(22)17-25(26)29(31)35(2)3)30(37)33-23-14-12-20(13-15-23)24-10-6-7-11-28(24)40(32,38)39/h4-18,31H,1-3H3,(H,33,37)(H2,32,38,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against tissue plasminogen activator |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114450
(2-(3-Carbamimidoyl-naphthalen-2-yl)-5-methyl-2H-py...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C(N)=N Show InChI InChI=1S/C28H24N6O3S/c1-17-14-25(34(33-17)24-16-20-7-3-2-6-19(20)15-23(24)27(29)30)28(35)32-21-12-10-18(11-13-21)22-8-4-5-9-26(22)38(31,36)37/h2-16H,1H3,(H3,29,30)(H,32,35)(H2,31,36,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114433
(2-(3-Methanesulfonyl-naphthalen-2-yl)-5-methyl-2H-...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1S(C)(=O)=O Show InChI InChI=1S/C28H24N4O5S2/c1-18-15-25(32(31-18)24-16-20-7-3-4-8-21(20)17-27(24)38(2,34)35)28(33)30-22-13-11-19(12-14-22)23-9-5-6-10-26(23)39(29,36)37/h3-17H,1-2H3,(H,30,33)(H2,29,36,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114448
(2-[3-(4,5-Dihydro-1H-imidazol-2-yl)-naphthalen-2-y...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C1=NCCN1 |t:40| Show InChI InChI=1S/C30H26N6O3S/c1-19-16-27(30(37)34-23-12-10-20(11-13-23)24-8-4-5-9-28(24)40(31,38)39)36(35-19)26-18-22-7-3-2-6-21(22)17-25(26)29-32-14-15-33-29/h2-13,16-18H,14-15H2,1H3,(H,32,33)(H,34,37)(H2,31,38,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114449
(3-[3-Methyl-5-(2'-sulfamoyl-biphenyl-4-ylcarbamoyl...)Show SMILES COC(=O)c1cc2ccccc2cc1-n1nc(C)cc1C(=O)Nc1ccc(cc1)-c1ccccc1S(N)(=O)=O Show InChI InChI=1S/C29H24N4O5S/c1-18-15-26(33(32-18)25-17-21-8-4-3-7-20(21)16-24(25)29(35)38-2)28(34)31-22-13-11-19(12-14-22)23-9-5-6-10-27(23)39(30,36)37/h3-17H,1-2H3,(H,31,34)(H2,30,36,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114437
(2-(3-Carbamoyl-naphthalen-2-yl)-5-methyl-2H-pyrazo...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C(N)=O Show InChI InChI=1S/C28H23N5O4S/c1-17-14-25(33(32-17)24-16-20-7-3-2-6-19(20)15-23(24)27(29)34)28(35)31-21-12-10-18(11-13-21)22-8-4-5-9-26(22)38(30,36)37/h2-16H,1H3,(H2,29,34)(H,31,35)(H2,30,36,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against tissue plasminogen activator |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114442
(2-(3-Hydroxy-naphthalen-2-yl)-5-methyl-2H-pyrazole...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1O Show InChI InChI=1S/C27H22N4O4S/c1-17-14-24(31(30-17)23-15-19-6-2-3-7-20(19)16-25(23)32)27(33)29-21-12-10-18(11-13-21)22-8-4-5-9-26(22)36(28,34)35/h2-16,32H,1H3,(H,29,33)(H2,28,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against tissue plasminogen activator |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114438
(2-(3-Bromo-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1Br Show InChI InChI=1S/C27H21BrN4O3S/c1-17-14-25(32(31-17)24-16-20-7-3-2-6-19(20)15-23(24)28)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-26(22)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against tissue plasminogen activator |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114447
(3-[3-Methyl-5-(2'-sulfamoyl-biphenyl-4-ylcarbamoyl...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C(O)=O Show InChI InChI=1S/C28H22N4O5S/c1-17-14-25(32(31-17)24-16-20-7-3-2-6-19(20)15-23(24)28(34)35)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-26(22)38(29,36)37/h2-16H,1H3,(H,30,33)(H,34,35)(H2,29,36,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against tissue plasminogen activator |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114436
(2-(6-Chloro-naphthalen-2-yl)-5-methyl-2H-pyrazole-...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2cc(Cl)ccc2c1 Show InChI InChI=1S/C27H21ClN4O3S/c1-17-14-25(32(31-17)23-13-9-19-15-21(28)10-6-20(19)16-23)27(33)30-22-11-7-18(8-12-22)24-4-2-3-5-26(24)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against coagulation factor Xa |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114445
(2-(6-Hydroxy-naphthalen-2-yl)-5-methyl-2H-pyrazole...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2cc(O)ccc2c1 Show InChI InChI=1S/C27H22N4O4S/c1-17-14-25(31(30-17)22-12-8-20-16-23(32)13-9-19(20)15-22)27(33)29-21-10-6-18(7-11-21)24-4-2-3-5-26(24)36(28,34)35/h2-16,32H,1H3,(H,29,33)(H2,28,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114435
(2-(3-Cyano-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C#N Show InChI InChI=1S/C28H21N5O3S/c1-18-14-26(33(32-18)25-16-21-7-3-2-6-20(21)15-22(25)17-29)28(34)31-23-12-10-19(11-13-23)24-8-4-5-9-27(24)37(30,35)36/h2-16H,1H3,(H,31,34)(H2,30,35,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114446
(5-Methyl-2-naphthalen-2-yl-2H-pyrazole-3-carboxyli...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2ccccc2c1 Show InChI InChI=1S/C27H22N4O3S/c1-18-16-25(31(30-18)23-15-12-19-6-2-3-7-21(19)17-23)27(32)29-22-13-10-20(11-14-22)24-8-4-5-9-26(24)35(28,33)34/h2-17H,1H3,(H,29,32)(H2,28,33,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against tissue plasminogen activator |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114439
(2-(6-Bromo-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2cc(Br)ccc2c1 Show InChI InChI=1S/C27H21BrN4O3S/c1-17-14-25(32(31-17)23-13-9-19-15-21(28)10-6-20(19)16-23)27(33)30-22-11-7-18(8-12-22)24-4-2-3-5-26(24)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against tissue plasminogen activator |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114444
(2-(3-Aminomethyl-naphthalen-2-yl)-5-methyl-2H-pyra...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1CN Show InChI InChI=1S/C28H25N5O3S/c1-18-14-26(33(32-18)25-16-21-7-3-2-6-20(21)15-22(25)17-29)28(34)31-23-12-10-19(11-13-23)24-8-4-5-9-27(24)37(30,35)36/h2-16H,17,29H2,1H3,(H,31,34)(H2,30,35,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114432
(2-(3-Hydroxymethyl-naphthalen-2-yl)-5-methyl-2H-py...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1CO Show InChI InChI=1S/C28H24N4O4S/c1-18-14-26(32(31-18)25-16-21-7-3-2-6-20(21)15-22(25)17-33)28(34)30-23-12-10-19(11-13-23)24-8-4-5-9-27(24)37(29,35)36/h2-16,33H,17H2,1H3,(H,30,34)(H2,29,35,36) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114443
(5-Methyl-2-(3-sulfamoyl-naphthalen-2-yl)-2H-pyrazo...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1S(N)(=O)=O Show InChI InChI=1S/C27H23N5O5S2/c1-17-14-24(32(31-17)23-15-19-6-2-3-7-20(19)16-26(23)39(29,36)37)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-25(22)38(28,34)35/h2-16H,1H3,(H,30,33)(H2,28,34,35)(H2,29,36,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against tissue plasminogen activator |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114434
(2-(3-Fluoro-naphthalen-2-yl)-5-methyl-2H-pyrazole-...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1F Show InChI InChI=1S/C27H21FN4O3S/c1-17-14-25(32(31-17)24-16-20-7-3-2-6-19(20)15-23(24)28)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-26(22)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against tissue plasminogen activator |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114441
(2-(6-Methoxy-naphthalen-2-yl)-5-methyl-2H-pyrazole...)Show SMILES COc1ccc2cc(ccc2c1)-n1nc(C)cc1C(=O)Nc1ccc(cc1)-c1ccccc1S(N)(=O)=O Show InChI InChI=1S/C28H24N4O4S/c1-18-15-26(32(31-18)23-13-9-21-17-24(36-2)14-10-20(21)16-23)28(33)30-22-11-7-19(8-12-22)25-5-3-4-6-27(25)37(29,34)35/h3-17H,1-2H3,(H,30,33)(H2,29,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Kallikrein-1
(Homo sapiens (Human)) | BDBM50114432
(2-(3-Hydroxymethyl-naphthalen-2-yl)-5-methyl-2H-py...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1CO Show InChI InChI=1S/C28H24N4O4S/c1-18-14-26(32(31-18)25-16-21-7-3-2-6-20(21)15-22(25)17-33)28(34)30-23-12-10-19(11-13-23)24-8-4-5-9-27(24)37(29,35)36/h2-16,33H,17H2,1H3,(H,30,34)(H2,29,35,36) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against kallikrein |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114439
(2-(6-Bromo-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2cc(Br)ccc2c1 Show InChI InChI=1S/C27H21BrN4O3S/c1-17-14-25(32(31-17)23-13-9-19-15-21(28)10-6-20(19)16-23)27(33)30-22-11-7-18(8-12-22)24-4-2-3-5-26(24)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Kallikrein-1
(Homo sapiens (Human)) | BDBM50114439
(2-(6-Bromo-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2cc(Br)ccc2c1 Show InChI InChI=1S/C27H21BrN4O3S/c1-17-14-25(32(31-17)23-13-9-19-15-21(28)10-6-20(19)16-23)27(33)30-22-11-7-18(8-12-22)24-4-2-3-5-26(24)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against kallikrein |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Kallikrein-1
(Homo sapiens (Human)) | BDBM50114435
(2-(3-Cyano-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1C#N Show InChI InChI=1S/C28H21N5O3S/c1-18-14-26(33(32-18)25-16-21-7-3-2-6-20(21)15-22(25)17-29)28(34)31-23-12-10-19(11-13-23)24-8-4-5-9-27(24)37(30,35)36/h2-16H,1H3,(H,31,34)(H2,30,35,36) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against kallikrein |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Kallikrein-1
(Homo sapiens (Human)) | BDBM50114446
(5-Methyl-2-naphthalen-2-yl-2H-pyrazole-3-carboxyli...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2ccccc2c1 Show InChI InChI=1S/C27H22N4O3S/c1-18-16-25(31(30-18)23-15-12-19-6-2-3-7-21(19)17-23)27(32)29-22-13-10-20(11-14-22)24-8-4-5-9-26(24)35(28,33)34/h2-17H,1H3,(H,29,32)(H2,28,33,34) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against kallikrein |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50114445
(2-(6-Hydroxy-naphthalen-2-yl)-5-methyl-2H-pyrazole...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1ccc2cc(O)ccc2c1 Show InChI InChI=1S/C27H22N4O4S/c1-17-14-25(31(30-17)22-12-8-20-16-23(32)13-9-19(20)15-22)27(33)29-21-10-6-18(7-11-21)24-4-2-3-5-26(24)36(28,34)35/h2-16,32H,1H3,(H,29,33)(H2,28,34,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against plasmin |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |
Kallikrein-1
(Homo sapiens (Human)) | BDBM50114438
(2-(3-Bromo-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)Show SMILES Cc1cc(C(=O)Nc2ccc(cc2)-c2ccccc2S(N)(=O)=O)n(n1)-c1cc2ccccc2cc1Br Show InChI InChI=1S/C27H21BrN4O3S/c1-17-14-25(32(31-17)24-16-20-7-3-2-6-19(20)15-23(24)28)27(33)30-21-12-10-18(11-13-21)22-8-4-5-9-26(22)36(29,34)35/h2-16H,1H3,(H,30,33)(H2,29,34,35) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against kallikrein |
Bioorg Med Chem Lett 12: 1651-5 (2002)
BindingDB Entry DOI: 10.7270/Q2VT1RFZ |
More data for this Ligand-Target Pair | |